Epstein-Barr Virus: A Key Player in Severe Brain Infections

CSF analysis revealed higher protein levels and significantly lower glucose levels in EBV cases.

A recent study highlighted the significant role of the Epstein-Barr virus (EBV) in encephalitis, a serious brain infection. Researchers from West China Hospital examined 364 patients with encephalitis between June 2020 and April 2021. Their findings were published in the Virology Journal (Liu et al., 2025).

Key Findings

EBV was detected in the cerebrospinal fluid (CSF) of 23.6% of patients, with 39 cases confirmed as EBV-associated encephalitis. Patients affected by EBV encephalitis showed distinctive symptoms compared to those with other viral encephalitis.

  • CSF analysis revealed higher protein levels and significantly lower glucose levels in EBV cases.
  • MRI scans showed more frequent meningeal involvement in EBV patients (30.6%) compared to other herpes-virus infections (6.5%).
  • Researchers identified immunosuppression and active EBV infection in the blood as key risk factors.

Age and Immune Status Matter

EBV encephalitis was more common in older patients and those with weakened immunity. HIV infection or immunosuppressive treatments especially made patients vulnerable. The study also identified lower T-lymphocyte counts in EBV encephalitis patients. This suggests that EBV not only affects the brain but also significantly impacts the immune system.

A Unique Brain Infection

EBV encephalitis differs from other herpes-virus infections. It is marked by higher CSF protein levelsreduced glucose, and distinct immune changes. These findings suggest that EBV may enter the brain through weakened barriers, like the blood-brain barrier.

Call for Attention

The researchers emphasized the importance of early testing and treatment for EBV-associated encephalitis. They also recommended further studies to explore its link with conditions like autoimmune diseases or subsequent immune complications.

Conclusion

This study underscores EBV’s role as a serious pathogen in encephalitis. Its findings highlight the need for better awareness and targeted therapies for this type of brain infection.

Reference


Liu, Z., Peng, A., Huang, L., Sha, L., Tang, Y., Zhou, Y., & Chen, L. (2025). Clinical features and risk factors for Epstein-Barr virus-associated encephalitis: A retrospective cohort study. Virology Journal, 22(141). https://doi.org/10.1186/s12985-025-02768-w

Additionally, to stay updated with the latest developments in STEM research, visit ENTECH Online. Basically, this is our digital magazine for science, technology, engineering, and mathematics. Furthermore, at ENTECH Online, you’ll find a wealth of information.

Leave Your Comment

Warning